Abstract:In recent years, pretraining models have made significant advancements in the fields of natural language processing (NLP), computer vision (CV), and life sciences. The significant advancements in NLP and CV are predominantly driven by the expansion of model parameters and data size, a phenomenon now recognized as the scaling laws. However, research exploring scaling law in molecular pretraining models remains unexplored. In this work, we present Uni-Mol2 , an innovative molecular pretraining model that leverages a two-track transformer to effectively integrate features at the atomic level, graph level, and geometry structure level. Along with this, we systematically investigate the scaling law within molecular pretraining models, characterizing the power-law correlations between validation loss and model size, dataset size, and computational resources. Consequently, we successfully scale Uni-Mol2 to 1.1 billion parameters through pretraining on 800 million conformations, making it the largest molecular pretraining model to date. Extensive experiments show consistent improvement in the downstream tasks as the model size grows. The Uni-Mol2 with 1.1B parameters also outperforms existing methods, achieving an average 27% improvement on the QM9 and 14% on COMPAS-1D dataset.
Abstract:Recently deep learning based quantitative structure-activity relationship (QSAR) models has shown surpassing performance than traditional methods for property prediction tasks in drug discovery. However, most DL based QSAR models are restricted to limited labeled data to achieve better performance, and also are sensitive to model scale and hyper-parameters. In this paper, we propose Uni-QSAR, a powerful Auto-ML tool for molecule property prediction tasks. Uni-QSAR combines molecular representation learning (MRL) of 1D sequential tokens, 2D topology graphs, and 3D conformers with pretraining models to leverage rich representation from large-scale unlabeled data. Without any manual fine-tuning or model selection, Uni-QSAR outperforms SOTA in 21/22 tasks of the Therapeutic Data Commons (TDC) benchmark under designed parallel workflow, with an average performance improvement of 6.09\%. Furthermore, we demonstrate the practical usefulness of Uni-QSAR in drug discovery domains.
Abstract:Attentional blink (AB) is a biological effect, showing that for 200 to 500ms after paying attention to one visual target, it is difficult to notice another target that appears next, and attentional blink magnitude (ABM) is a indicating parameter to measure the degree of this effect. Researchers have shown that different categories of images can access the consciousness of human mind differently, and produce different ranges of ABM values. So in this paper, we compare two different types of images, categorized as animal and object, by predicting ABM values directly from image features extracted from convolutional neural network (CNN), and indirectly from functional magnetic resonance imaging (fMRI) data. First, for two sets of images, we separately extract their average features from layers of Alexnet, a classic model of CNN, then input the features into a trained linear regression model to predict ABM values, and we find higher-level instead of lower-level image features determine the categorical difference in AB effect, and mid-level image features predict ABM values more correctly than low-level and high-level image features. Then we employ fMRI data from different brain regions collected when the subjects viewed 50 test images to predict ABM values, and conclude that brain regions covering relatively broader areas, like LVC, HVC and VC, perform better than other smaller brain regions, which means AB effect is more related to synthetic impact of several visual brain regions than only one particular visual regions.